Ozempic maker Novo Nordisk gets more weight loss drug competition as a rival releases promising data ...Middle East

Quartz - Economy
Ozempic maker Novo Nordisk gets more weight loss drug competition as a rival releases promising data
Viking Therapeutics stock jumped 25% to $87 per share on Tuesday after the pharmaceutical company released promising clinical trial results for its experimental weight loss pill. It’s the latest development in the race among several pharmaceutical companies to introduce new weight loss drug alternatives to the current…Read more...

Hence then, the article about ozempic maker novo nordisk gets more weight loss drug competition as a rival releases promising data was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ozempic maker Novo Nordisk gets more weight loss drug competition as a rival releases promising data )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News